Skip to main content
Erschienen in: Tumor Biology 4/2013

01.08.2013 | Research Article

Mitochondrial D310 instability in Asian Indian breast cancer patients

verfasst von: Mohammed A. Alhomidi, Bhavani Vedicherla, Sireesha Movva, Prabhakar K. Rao, Yog R. Ahuja, Qurratulain Hasan

Erschienen in: Tumor Biology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Somatic mutations in mitochondrial DNA (mtDNA) have been demonstrated in various tumors. Mitochondrial D-loop is a non-coding region in the mitochondrial genome, which has essential transcription and replication elements, and alterations in this region may affect both these processes. The D-loop has a poly-C tract (PCT) located between 303 and 315 nucleotides known as D310, which has been identified as a frequent hot spot mutation region in human neoplasia. In the present study, 77 pairs of breast tumor and adjacent non-tumorous tissue samples were analyzed by polymerase chain reaction–single-strand conformational polymorphism, restriction fragment length polymorphism, and sequencing to evaluate the frequency of D310 (PCT) mutations and its association with clinicopathologic parameters of breast cancer. Alterations were detected in 25 of 77 (32.5 %) breast cancer samples; these included 7/25 (28 %) cases with heteroplasmy. This is the first study from Asian Indian breast cancer (BC) patients indicating a relatively high frequency of D310 mutations, suggesting that mtDNA instability at D310 may be a common characteristic of BC. However, 66.7 % of the alterations were observed in stage II BC, indicating that this may be a more important change for early progression of the disease rather than its initiation.
Literatur
1.
Zurück zum Zitat Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Childhood. 2004;4:5. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Childhood. 2004;4:5.
2.
Zurück zum Zitat Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010;2285–92. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010;2285–92.
3.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRef
4.
Zurück zum Zitat Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007;18(3):593.PubMedCrossRef Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007;18(3):593.PubMedCrossRef
5.
Zurück zum Zitat Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public health. 1996;17(1):47–67.CrossRef Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public health. 1996;17(1):47–67.CrossRef
6.
Zurück zum Zitat Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009;125(7):1663–70.PubMedCrossRef Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009;125(7):1663–70.PubMedCrossRef
7.
Zurück zum Zitat Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, et al. Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst. 1993;85(22):1819.PubMedCrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, et al. Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst. 1993;85(22):1819.PubMedCrossRef
8.
9.
Zurück zum Zitat Anderson S, Bankier A, Barrell BG, De Bruijn M, Coulson A, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.PubMedCrossRef Anderson S, Bankier A, Barrell BG, De Bruijn M, Coulson A, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.PubMedCrossRef
10.
Zurück zum Zitat Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2(1):67–71.PubMedCrossRef Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2(1):67–71.PubMedCrossRef
11.
Zurück zum Zitat Ye C, Shu XO, Pierce L, Wen W, Courtney R, Gao YT, et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat. 2010;119(2):431–6.PubMedCrossRef Ye C, Shu XO, Pierce L, Wen W, Courtney R, Gao YT, et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat. 2010;119(2):431–6.PubMedCrossRef
12.
Zurück zum Zitat Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524–32.PubMedCrossRef Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524–32.PubMedCrossRef
13.
14.
Zurück zum Zitat Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res Rev Mutat Res. 2001;488(1):9–23.CrossRef Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res Rev Mutat Res. 2001;488(1):9–23.CrossRef
15.
Zurück zum Zitat Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med. 2007;7(1):121–31.PubMedCrossRef Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med. 2007;7(1):121–31.PubMedCrossRef
16.
Zurück zum Zitat Lee HC, Yin PH, Lin JINC, Wu CC, Chen CYI, Wu CWUN, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042(1):109–22.PubMedCrossRef Lee HC, Yin PH, Lin JINC, Wu CC, Chen CYI, Wu CWUN, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042(1):109–22.PubMedCrossRef
17.
Zurück zum Zitat Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636.PubMed Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636.PubMed
18.
Zurück zum Zitat Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001;61(19):7015.PubMed Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001;61(19):7015.PubMed
19.
Zurück zum Zitat Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155.PubMed Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155.PubMed
20.
Zurück zum Zitat Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80–3.PubMedCrossRef Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80–3.PubMedCrossRef
21.
Zurück zum Zitat Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med. 2002;2(1):1–19.CrossRef Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med. 2002;2(1):1–19.CrossRef
22.
Zurück zum Zitat Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10(2):674–701.PubMedCrossRef Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10(2):674–701.PubMedCrossRef
23.
Zurück zum Zitat Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001;61(20):7623.PubMed Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001;61(20):7623.PubMed
24.
Zurück zum Zitat Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed
25.
Zurück zum Zitat Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19(7):802–15.PubMedCrossRef Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19(7):802–15.PubMedCrossRef
26.
Zurück zum Zitat Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60(15):4231.PubMed Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60(15):4231.PubMed
27.
Zurück zum Zitat Dakubo GD. Mitochondrial genetics and cancer. Berlin: Springer; 2010.CrossRef Dakubo GD. Mitochondrial genetics and cancer. Berlin: Springer; 2010.CrossRef
28.
Zurück zum Zitat Salas A, Yao YG, Macaulay V, Vega A, Carracedo Á, Bandelt HJ. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005;2(11):e296.PubMedCrossRef Salas A, Yao YG, Macaulay V, Vega A, Carracedo Á, Bandelt HJ. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005;2(11):e296.PubMedCrossRef
29.
Zurück zum Zitat Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, et al. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res. 2007;13(15):4331.PubMedCrossRef Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, et al. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res. 2007;13(15):4331.PubMedCrossRef
30.
Zurück zum Zitat Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661.PubMedCrossRef Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661.PubMedCrossRef
31.
Zurück zum Zitat Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23(15):3517–25.PubMedCrossRef Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23(15):3517–25.PubMedCrossRef
32.
Zurück zum Zitat Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African–American women. Cancer Genet Cytogenet. 2008;181(1):16–9.PubMedCrossRef Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African–American women. Cancer Genet Cytogenet. 2008;181(1):16–9.PubMedCrossRef
Metadaten
Titel
Mitochondrial D310 instability in Asian Indian breast cancer patients
verfasst von
Mohammed A. Alhomidi
Bhavani Vedicherla
Sireesha Movva
Prabhakar K. Rao
Yog R. Ahuja
Qurratulain Hasan
Publikationsdatum
01.08.2013
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2013
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0793-0

Weitere Artikel der Ausgabe 4/2013

Tumor Biology 4/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.